Cinven has bought the environmental science arm of pharma company Bayer for USD 2.6bn (EUR 2.4bn), the latest in a slew of industrial carve-outs by the London-based private equity firm
Cinven has bought the environmental science arm of pharma company Bayer for USD 2.6bn (EUR 2.4bn), the latest in a slew of industrial carve-outs by the London-based private equity firm